What is H.C. Wainwright's price target for MDGL?

H.C. Wainwright's latest stated price target for Madrigal Pharmaceuticals Inc. (MDGL) is $500, from its action on Sep 4, 2025.

What is H.C. Wainwright's rating on MDGL?

H.C. Wainwright rates MDGL Buy, a bullish rating, as of Sep 4, 2025.

When did H.C. Wainwright last change its view on MDGL?

On Sep 4, 2025, H.C. Wainwright resumes coverage at Buy, price target $500.

Analyst firms · H.C. Wainwright · MDGL

H.C. Wainwright MDGL price target and rating history

Madrigal Pharmaceuticals Inc. (MDGL) · Health Care

H.C. Wainwright rates Madrigal Pharmaceuticals Inc. (MDGL) Buy with a $500 price target, as of its latest action on Sep 4, 2025. It has published 4 rating actions on MDGL since August 2021, including 0 upgrades and 0 downgrades. Across 5 firms with a MDGL price target in the last 12 months, the median target is $704.

Current rating: Buy
Price target: $500
Median target, all firms: $704
Actions on MDGL: 4

H.C. Wainwright price target on MDGL

H.C. Wainwright price target on MDGL, each point a stated target, August 2021 to September 2025.

Every H.C. Wainwright rating on MDGL

Sep 4, 2025
ResumeH.C. Wainwright resumes coverage at Buy, price target $500
Feb 27, 2025
ReiterateH.C. Wainwright raises its price target to $405 from $400, keeps Buy
Dec 19, 2022
ReiterateH.C. Wainwright raises its price target to $225 from $170, keeps Buy
Aug 11, 2021
ReiterateH.C. Wainwright cuts its price target to $170 from $184, keeps Buy

How other firms rate MDGL

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Goldman Sachs	Buy	$704	Sep 24, 2026
Citigroup	Buy	$725	Sep 23, 2026
Wolfe Research	Outperform	$605	Aug 4, 2026
Wells Fargo	Overweight	$685	Jul 27, 2026
Barclays	Overweight	$964	Jan 28, 2026

Questions about H.C. Wainwright and MDGL

What is H.C. Wainwright's price target for MDGL?: H.C. Wainwright's latest stated price target for Madrigal Pharmaceuticals Inc. (MDGL) is $500, from its action on Sep 4, 2025.
What is H.C. Wainwright's rating on MDGL?: H.C. Wainwright rates MDGL Buy, a bullish rating, as of Sep 4, 2025.
When did H.C. Wainwright last change its view on MDGL?: On Sep 4, 2025, H.C. Wainwright resumes coverage at Buy, price target $500.
How does H.C. Wainwright's MDGL target compare with other analysts?: Across 5 firms with a MDGL price target in the last 12 months, the median target is $704.

More MDGL rating histories

All H.C. Wainwright ratings MDGL news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.